COVID-19 Omicron variant poses risk for worldwide infection

COVID-19 Omicron variant poses risk for worldwide infection

The U.S. is on high alert as the Omicron variant of the coronavirus spreads throughout the world. Scientists are researching how effective current vaccines are against the new variant. CBS News reporter Alexander Tin joins CBSN “Red and Blue” anchor…

CDC considers COVID-19 vaccine booster eligibility for all U.S. adults

CDC considers COVID-19 vaccine booster eligibility for all U.S. adults

The CDC is expected to recommend all U.S. adults should have access to COVID-19 vaccine booster shots. CBS News researcher and reporter Max Bayer spoke with CBSN’s Tanya Rivero about what officials are considering. CBSN is CBS News’ 24/7 digital…

U.S. COVID cases rise ahead of holidays, straining some hospitals

U.S. COVID cases rise ahead of holidays, straining some hospitals

COVID-19 cases are on the rise in the U.S. ahead of the holidays. Emergency medicine physician Dr. Hilary Fairbrother joins CBSN’s Lana Zak for more. CBSN is CBS News’ 24/7 digital streaming news service featuring live, anchored coverage available for…

Moderna asks FDA to expand COVID booster eligibility to all adults

Moderna asks FDA to expand COVID booster eligibility to all adults

Moderna has formally requested the FDA authorize expansion of its COVID-19 booster shot to all adults. Federal health officials are expected to authorize expansion of Pfizer’s booster this week. It comes as cases continue to rise across the U.S. Emergency…

COVID-19 cases on the rise ahead of Thanksgiving

COVID-19 cases on the rise ahead of Thanksgiving

The CDC reports over 1 million children ages 5 to 11 have received the first dose of Pfizer’s pediatric vaccine. This comes as several states and New York City begin expanding booster eligibility to all adults. Director of vaccine research…

Appeals court halts Biden COVID-19 vaccine rule for large companies

Appeals court halts Biden COVID-19 vaccine rule for large companies

The Biden administration is pushing back after a federal appeals court temporarily halted a COVID-19 vaccine mandate for large businesses. CBS New senior White House correspondent Weijia Jiang joins CBSN’s Elaine Quijano from the White House to discuss. CBSN is…

Millions of children begin receiving Pfizer's COVID-19 vaccine

Millions of children begin receiving Pfizer’s COVID-19 vaccine

The CDC unanimously recommended Pfizer’s low dose COVID-19 vaccine for kids ages 5 to 11. Drugstores like CVS and Walgreens are already setting up appointments, but some parents are hesitant about getting their kids vaccinated. Family medicine physician and CEO…

Doctor weighs in on Pfizer's COVID-19 vaccine for kids as young as 5

Doctor weighs in on Pfizer’s COVID-19 vaccine for kids as young as 5

Roughly 28 million grade-school age children are now eligible to receive the COVID-19 vaccine. The CDC recommended the low-dose version of Pfizer’s vaccine for kids between the ages of 5 and 11. Dr. Rashmi Jain, a concierge pediatrician and founder…

Doctor discusses CDC's recommendation of Pfizer's lower-dose COVID-19 vaccine for children ages 5…

Doctor discusses CDC’s recommendation of Pfizer’s lower-dose COVID-19 vaccine for children ages 5…

Children ages 5 to 11 are now eligible for a lower-dose version of Pfizer’s COVID-19 vaccine, after the CDC issued its recommendation on Tuesday. Dr. Julie Morita, the executive vice president of the Robert Wood Johnson Foundation, joined CBSN to…

Pfizer's COVID-19 vaccine could be available soon for kids ages 5 to 11

Pfizer’s COVID-19 vaccine could be available soon for kids ages 5 to 11

An FDA advisory panel has voted to endorse Pfizer’s coronavirus vaccine for children ages 5 to 11 and a final decision is expected soon. CBS News’ Debra Alfarone reports, and then CBS News reporter Alex Tin joins CBSN’s “Red &…